4
Changes in Ownership
Oric Pharmaceuticals, Inc. Filed Acc 0001415889-24-016903
Options or other derivatives
- Director acquired 25,600 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Heyman Richard A. Director | 2024-06-12 | Grant or award · Stock Option (right to buy) | +25,600 | 25,600 | D | ||
Loading xslF345X05/form4-06142024_080630.xml…